Chronic immune (idiopathic) thrombocytopenic purpura (ITP): Romiplate is indicated for adult chronic immune (idiopathic) thrombocytopenic purpura (ITP) splenectomised patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins) (see Dosage & Administration and Pharmacology: Pharmacodynamics under Actions).
Romiplate may be considered as second line treatment for adult non-splenectomised patients where surgery is contraindicated.
Aplastic anaemia: Romiplate is indicated for adults with moderate to severe aplastic anaemia refractory to conventional therapies.